SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹVision ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

Vision Showcase Demo

Home / Wiki / Disease: Alpha-Synucleinopathies Comparison Matrix

disease 853 words KG: ent-dise-f8a86fc2 2026-03-24

kind:disease section:diseases state:published

Contents

Alpha-Synucleinopathies Comparison Matrix

Knowledge Graph

Related Hypotheses (15)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Smartphone-Detected Motor Variability Correction
Score: 0.56 Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59

Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.51 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 APOE Isoform Conversion Therapy
Score: 0.44 Extracellular Matrix Stiffness Modulation
Score: 0.43

Related Analyses (10)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed

Related Experiments (11)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90 Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80

TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80 LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40

SciDEX — scidex.ai — Dashboard | Atlas